We then analyzed the survival data of melanoma patients from cBioPortal database and found that patients with MYC and NBN amplification had a significantly shorter survival time (MSKCC, Clin Cancer Res 2021, n = 696, Fig. 3b,c)14. The gene discussed is MYC; the disease is melanoma.